Phibro Animal Health
PAHC
148 hedge funds and large institutions have $395M invested in Phibro Animal Health in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 50 increasing their positions, 58 reducing their positions, and 13 closing their positions.
0.66% more ownership
Funds ownership: 100.96% → 101.62% (+0.66%)
3% less capital invested
Capital invested by funds: $409M → $395M (-$13.4M)
8% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 13
3% less funds holding
Funds holding: 153 → 148 (-5)
14% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 58
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pzena Investment Management
New York
|
+$6.74M |
| 2 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$4.67M |
| 3 |
Morgan Stanley
New York
|
+$2.39M |
| 4 |
BlackRock
New York
|
+$2.37M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$564K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FMI
Fiduciary Management Inc
Milwaukee,
Wisconsin
|
-$5.21M |
| 2 |
Millennium Management
New York
|
-$1.51M |
| 3 |
Two Sigma Investments
New York
|
-$1.19M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$1.18M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.16M |
PAHC Hedge Fund Activity: Q2 2022 in Review
148 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q2 2022, worth a combined $395M — down 3.3% from $409M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of PAHC and 12 opened new positions — a net loss of 1 holder — while 58 trimmed existing stakes and 50 added.
The largest buyer was Pzena Investment Management, adding an estimated $6.74M. The largest seller was Fiduciary Management Inc, cutting an estimated $5.21M.
- 148 institutional investors held Phibro Animal Health (PAHC) as of Q2 2022, down from 153 in Q1 2022.
- Funds reported $395M of Phibro Animal Health stock for Q2 2022, down 3.3% quarter-over-quarter.
- 12 funds opened new Phibro Animal Health positions in Q2 2022 and 13 closed out, a net change of -1 holder.
- The largest Phibro Animal Health buyer in Q2 2022 was Pzena Investment Management, an estimated $6.74M added.
- The largest Phibro Animal Health seller in Q2 2022 was Fiduciary Management Inc, an estimated $5.21M sold.
Based on aggregated 13F filings for Q2 2022.